Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 28 for “"B cell activating factor"”.
-
Impact of B cell Activating Factor (BAFF) on Autoimmune Neuroinflammation
… disease, is mediated by myelin-reactive CD4+ T cells. Anti-CD20 B cell depletion therapies are highly effective at treating MS, but the mechanisms underpinning this protection are poorly defined. Paradoxically, removal of B lineage cells by targeting B cell survival factors, including the B cell …
-
Molecular and immunological mechanisms of B cell activating factor-driven B cell dysregulation in CVID
… with profound pulmonary infiltration of T and B cells, granulomatous inflammation, and dysregulated B cell activation, suggesting that intrinsic immune abnormalities contribute to its development. B cell depletion therapy ameliorates disease in a subset of CVID ILD, yet variability in treatment …
-
B CELL ACTIVATING FACTOR AND MATRIX METALLOPROTEINASE-2 AS NOVEL MODULATORS OF INSULIN RESISTANCE AND GLUCOSE UTILIZATION
… tissue mediated by the infiltration of immune cells. In recent years, many studies have highlighted the importance of understanding the interplay between the body's metabolic state and the activation of the immune system in type 2 diabetes. Here, we identify novel roles for B cell-activating …
-
The type I Interferon/B-cell activating factor axis in primary Sjogren's syndrome: Association of BAFF polymorphisms with premature atherosclerosis
ΣΚΟΠΟΣ: Να μελετήσουμε τη συσχέτιση γνωστών πολυμορφισμών του γονιδίου του BAFF και μιας μετάλλαξης του υποδοχέα του (BAFF-R) με σημεία πρώιμης αθηρωμάτωσης (υπερηχογραφική αξιολόγηση μέσης πάχυνσης του έσω χιτώνα (ΙΜΤ) και αθηρωματικής πλάκας) σε ασθενείς με 1θες σύνδρομο Sjogren (pSS). ΜΕΘΟΔΟΣ: …
-
Novel mechanisms involving B cell receptor (BCR) and B cell activating factor (BAFF) signaling pathways underlying human primary immunodeficiencies and malignancy
… and survival of human peripheral immature B cells relies on two critical signaling pathways: B cell receptor (BCR) signaling and the B cell activating factor (BAFF)/BAFF-receptor (BAFF-R) signaling axis. The quality of the BCR signal is regulated in a developmental manner. Self-reactive early …
-
Συμμετοχή του παράγοντα ενεργοποίησης Β-κυττάρων (B-cell activating factor-BAFF) στη σχετική με τη ρευματοειδή αρθρίτιδα και το σύνδρομο Sjogren Αθηροσκλήρωση
… pathogenetic mechanism. Even if traditional risk factors, such as hypertension, diabetes mellitus, hyperlipidemia, smoking, obesity and physical inactivity are found more frequently in the patient group, this imbalance does not seem to substantially explain mortality rate differences. Large cohort …
-
Η ιντερλευκίνη-17Α και ο ενεργοποιητικός παράγοντας των Β λεμφοκυττάρων σε ασθενείς με χρόνια ηπατίτιδα C και μικτή κρυοσφαιριναιμία: επιδράσεις της αντιιικής θεραπείας και συσχετίσεις με τη βιταμίνη D
… mixed cryoglobulinemia (MC). The importance of B-cell activating factor (BAFF) in MC has been described, but the role of interleukin (IL)-17A is less clear. Aim of the Study: The main objectives were to determine the levels of BAFF and IL-17A cytokines in patients with CHC with or without MC, and …
-
129Xe Magnetic Resonance Imaging Ventilation Phenotypes of Severe Asthma
… (interleukin-4, interleukin-6, interleukin-15, B-cell activating factor), total lung capacity, CT air-trapping, and CT mucus score (all p<0.05). They were not different with respect to their asthma control or medication requirement, and ~75% of each phenotype reported uncontrolled asthma …
-
CROSS-SECTIONAL ASSOCIATIONS BETWEEN INFLAMMATORY BIOMARKERS AND PHYSICAL HEALTH-RELATED QUALITY OF LIFE AMONG PARTICIPANTS IN THE MULTICENTER AIDS COHORT STUDY
… 27 (β =-2.1, 95% CI: -3.6, -0.6; p < 0.01) and B-cell activating factor (β =-2.6, 95% CI: -3.8, -1.3; p < 0.001) had lower physical HRQoL than participants in the lowest quintile of these biomarkers - we did not find significant differences in physical HRQoL by C-C chemokine ligand-2 or B-cell …
-
Die Wirkung des Zytokins BAFF auf die Expression von pro- und anti-apoptotischen bcl-2 Familienmitgliedern in B-Zellen des Huhnes
Effect of B-cell activating factor of the tumor necrosis factor family (BAFF) on the expression of pro- and anti-apoptotic bcl-2 family members in chicken B cells The recently discovered chicken cytokine BAFF (B-cell activating factor of the tumor necrosis factor family) was characterised as an …
-
Enhancement of the An1 Population by BAFF: Potential Role in Autoimmune Disease
… found to be essential for the homeostasis of B cells. Numerous studies have shown BAFF to be involved in the pathogenesis of autoimmune diseases, including Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis. In an effort to understand the role of BAFF in the pathogenesis of autoimmune …
-
Regulation of lymphocyte development and function by TRAF2 and TRAF3
Tumour necrosis factor receptor (TNFR) family members are widely expressed in cells of the immune system and are essential for the development and function of many immune cell types. The TNFR associated factor (TRAF) family are signal adapter molecules that are recruited to various members of the …
-
Ο ρόλος του γονιδίου και της πρωτεΐνης TACI σε ασθενείς με σαρκοείδωση
… is presumed to be dictated by enhanced T cell immunity deregulation, however studies have suggested that patients with sarcoidosis exhibit an augmented humoral immune response manifested by increased amount of circulating immunoglobulins and the presence of autoantibodies. However the …
-
Evaluating the Role of Early HIV-Specific T and B Cell Phenotypes and Interaction in Determining Downstream Antibody Function in HIV Infection
… Phenotypic characteristics of T and B cells, as well as interactions between these cells early in infection may affect the quality of antiviral antibodies. This study investigated the impact of the general and HIV-specific T and B cell phenotypes and interactions in early HIV infection …
-
INVESTIGATING B CELLS IN COMPARTMENTALIZED AND PERIPHERAL INFLAMMATION DURING CENTRAL NERVOUS SYSTEM AUTOIMMUNITY
… of the brain and spinal cord whereby immune cells collaborate to mediate demyelination. B cell depleting therapies (anti-CD20) are used to treat both MS and MOGAD, though it remains unknown whether treatment success can be attributed to targeting of peripheral B cells or those localized to …
-
The role of secondary lymphoid organs in baff induced autoimmune disease
… heterogeneous autoimmune diseases with strong B cell aspects. A proportion of SLE and SS patients exhibit elevated serum BAFF (B cell activating factor of the TNF family); BAFF plays a key role in B cell homeostasis, survival and tolerance. BAFF transgenic (Tg) mice develop nephritis and salivary …
-
The role of BAFF and its receptor in allergic airway inflammation
… by a complicated pathophysiology where many cells are participating. Among these cells, the eosinophils play a main role as well as T and B lymphocytes. The B cells are involved in the immune response by the massive production of IgE, which characterises atopic asthma. However, B cells have …
-
Brain-reactive antibodies in inflammatory and degenerative diseases of the central nervous system (CNS)
… anti-cluster of differentiation 20 (CD20) cell depletion therapy, ocrelizumab, beyond its effect on B-cell depletion. We propose that, in addition to targeting CD20-positive B cells, the elimination of CD20-positive T cells and changes in the levels of B-cell regulatory factors also play a …
-
Immune responses to malaria - Across early life, chronic exposure, and acute malaria
… of humoral immunity, including the roles of B-cell subsets and inflammatory mediators, remain incompletely understood. This thesis therefore investigates humoral immune responses to P. falciparum, focusing on antibody function, B-cell differentiation, and immune regulatory pathways across …
-
Μελέτη της σύστασης και της λειτουργίας της λιποπρωτεΐνης υψηλής πυκνότητας (HDL) σε παθολογικές καταστάσεις, καθώς και της ενίσχυσης των αθηροπροστατευτικών λειτουργιών της HDL με μικρά μόρια
… Belimumab is a monoclonal antibody against B-cell activating factor (BAFF), implicated in disease progression and associated with subclinical atherosclerosis. The analyses showed that belimumab treatment may improve the HDL atheroprotective properties and modify the HDL lipidomic signature in …
Page 1 of 2